[1]. Chenot, J.F., et al., Non-Specific Low Back Pain. Dtsch Arztebl Int, 2017. 114(51-52): p. 883-890.
[2]. Golob, A.L. and J.E. Wipf, Low back pain. Med Clin North Am, 2014. 98(3): p. 405-28.
[3]. Delitto, A., et al., Low back pain. J Orthop Sports Phys Ther, 2012. 42(4): p. A1-57.
[4]. Cassidy, J.D., L.J. Carroll and P. Cote, The Saskatchewan health and back pain survey. The prevalence of low back pain and related disability in Saskatchewan adults. Spine (Phila Pa 1976), 1998. 23(17): p. 1860-6; discussion 1867.
[5]. Deyo, R.A., S.K. Mirza and B.I. Martin, Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002. Spine (Phila Pa 1976), 2006. 31(23): p. 2724-7.
[6]. Heider, D., et al., Health Service Use, Costs, and Adverse Events Associated with Potentially Inappropriate Medication in Old Age in Germany: Retrospective Matched Cohort Study. Drugs Aging, 2017. 34(4): p. 289-301.
[7]. Jackson, T., et al., Prevalence of chronic pain in low-income and middle-income countries: a systematic review and meta-analysis. Lancet, 2015. 385 Suppl 2: p. S10.
[8]. Oliveira, C.B., et al., Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J, 2018. 27(11): p. 2791-2803.
[9]. Seco, J., F.M. Kovacs and G. Urrutia, The efficacy, safety, effectiveness, and cost-effectiveness of ultrasound and shock wave therapies for low back pain: a systematic review. Spine J, 2011. 11(10): p. 966-77.
[10]. Fricova, J. and R. Rokyta, The effects of extracorporeal shock wave therapy on pain patients. Neuro Endocrinol Lett, 2015. 36(2): p. 161-4.
[11]. Notarnicola, A. and B. Moretti, The biological effects of extracorporeal shock wave therapy (eswt) on tendon tissue. Muscles Ligaments Tendons J, 2012. 2(1): p. 33-7.
[12]. Jeon, J.H., et al., The effect of extracorporeal shock wave therapy on myofascial pain syndrome. Ann Rehabil Med, 2012. 36(5): p. 665-74.
[13]. Zhang, J., et al., Radial Extracorporeal Shock Wave Therapy Enhances the Proliferation and Differentiation of Neural Stem Cells by Notch, PI3K/AKT, and Wnt/beta-catenin Signaling. Sci Rep, 2017. 7(1): p. 15321.
[14]. Wei W., et al., Effectiveness of extracorporeal shock wave for low back pain: A protocol of systematic review. Medicine (Baltimore), 2019. 98(7): e14511.
[15]. Higgins, J.P., et al., The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 2011. 343: p. d5928.
[16]. Ostelo, R.W., et al., Clinically important outcomes in low back pain. Best Pract Res Clin Rheumatol, 2005, 19(4): p: 593-607.
[17]. Walewicz, K., et al., The Effectiveness Of Radial Extracorporeal Shock Wave Therapy In Patients With Chronic Low Back Pain: A Prospective, Randomized, Single-Blinded Pilot Study. Clin Interv Aging, 2019. 14: p. 1859-1869.
[18]. Celik, A., L. Altan and B.M. Okmen, The Effects Of Extracorporeal Shock Wave Therapy On Pain, Disability And Life Quality Of Chronic Low Back Pain Patients. Altern Ther Health Med, 2019.
[19]. Moon, Y.E., et al., Extracorporeal shock wave therapy for sacroiliac joint pain: A prospective, randomized, sham-controlled short-term trial. J Back Musculoskelet Rehabil, 2017. 30(4): p. 779-784.
[20]. Yang, J.H., et al., The analgesia effect and safety of extracorporeai shock wave therapy for condensing osteitis. Chinese Journal of Rehabilitation Medicine, 2015.30(7): p: 684-688.
[21]. Wu, K., et al., Clinical trial of extracorporeal shock wave therapy on acute subacute nonspecific low back pain. Chinese Journal of Disaster Medicine, 2016. 4(2): p: 81-84.
[22]. Zimmermann, R., et al., Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind, placebo-controlled study. Eur Urol, 2009. 56(3): p. 418-24.
[23]. Hausdorf, J., et al., [Molecular basis for pain mediating properties of extracorporeal shock waves]. Schmerz, 2004. 18(6): p. 492-7.
[24]. Holfeld, J., et al., Epicardial shock-wave therapy improves ventricular function in a porcine model of ischaemic heart disease. J Tissue Eng Regen Med, 2016. 10(12): p. 1057-1064.
[25]. Wang, C.J., et al., Shock wave therapy induces neovascularization at the tendon-bone junction. A study in rabbits. J Orthop Res, 2003. 21(6): p. 984-9.
[26]. Albrecht-Schgoer, K., et al., The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells. Circulation, 2012. 126(21): p. 2491-501.
[27]. Hausdorf, J., et al., Extracorporeal shockwave application to the distal femur of rabbits diminishes the number of neurons immunoreactive for substance P in dorsal root ganglia L5. Brain Res, 2008. 1207: p. 96-101.
[28]. Murata, R., et al., The effects of radial shock waves on gene transfer in rabbit chondrocytes in vitro. Osteoarthritis Cartilage, 2007. 15(11): p. 1275-82.
[29]. Notarnicola, A., et al., Extracorporeal shockwave therapy versus exercise program in patients with low back pain: short-term results of a randomised controlled trial. J Biol Regul Homeost Agents, 2018. 32(2): p. 385-389.
[30]. Padulo, J., et al., Muscles, Ligaments and Tendons Journal - Basic principles and recommendations in clinical and field Science Research: 2016 Update. Muscles Ligaments Tendons J, 2016. 6(1): p. 1-5.
[31]. Han, H., et al., The effects of extracorporeal shock wave therapy on pain, disability, and depression of chronic low back pain patients. J Phys Ther Sci, 2015. 27(2): p. 397-9.
[32]. Lee, S., D. Lee and J. Park, Effects of extracorporeal shockwave therapy on patients with chronic low back pain and their dynamic balance ability. J Phys Ther Sci, 2014. 26(1): p. 7-10.